ZK PHARMA LIMITED

Company Registration Number:
13896172 (England and Wales)

Unaudited statutory accounts for the year ended 28 February 2025

Period of accounts

Start date: 01 March 2024

End date: 28 February 2025

ZK PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2025

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

ZK PHARMA LIMITED

Company Information

for the Period Ended 28 February 2025




Director: Zipporah Kosgei
Registered office: 33
Checkley Road
Newcastle
England
ST5 7TN
Company Registration Number: 13896172 (England and Wales)

ZK PHARMA LIMITED

Balance sheet

As at 28 February 2025


Notes

2025
£

2024
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 30,280 28,160
Total current assets: 30,280 28,160
Creditors: amounts falling due within one year: 4 ( 2,255 ) ( 3,830 )
Net current assets (liabilities): 28,025 24,330
Total assets less current liabilities: 28,025 24,330
Total net assets (liabilities): 28,025 24,330

The notes form part of these financial statements

ZK PHARMA LIMITED

Balance sheet continued

As at 28 February 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 28,024 24,329
Shareholders funds: 28,025 24,330

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 March 2025
And Signed On Behalf Of The Board By:

Name: Zipporah Kosgei
Status: Director

The notes form part of these financial statements

ZK PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ZK PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 1 1

ZK PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 3. Off balance sheet disclosure

    No

ZK PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2025

4.Creditors: amounts falling due within one year note


2025
£

2024
£
Taxation and social security 2,255 3,830
Total 2,255 3,830

Amount due for Tax